BoJian Capital (BJC) is a healthcare focused investment firm on US-China cross border investments with offices in New York City and Beijing. BJC seeks to bring capital and strategic resources to the f ...

BROTHERS & Partners is a multi-family office actively seeking global investment opportunities in the life sciences and healthcare sectors. As conviction investors, we leverage our network of investor ...

Broad...opportunities with shorter horizons preferred; will also consider other situations with unique innovative "Assets".

Falcon Innovation Partners‌, a spin-off from Augeas, is a specialized boutique investment banking and consulting firm. Building upon Augeas's extensive global healthcare network across academia and in ...

Forward Equity Partners is a global, cross-border private equity firm based in Korea with focus on Healthcare / Life Science investments.

Good management team and top three in niche areas.

Halia Therapeutics is Leading the Science in novel drug discovery to eliminate chronic inflammation and promote longevity through treatment of neurodegeneration and inflammatory diseases.

We generate superior long-term absolute returns by applying an interdisciplinary outlook to traditional value investing.

Mayewell Capital focuses on (1) engage in Pre-IPO biotech equity investments (2) facilitate in/out-licensing between US/EU and Asia-Pacific regions of approved generics, 505b2, innovative drugs, as we ...

Mira Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapies for CNS, metabolic, and pain disorders. Its lead program, Ketamir-2, has an active IND ...